Actionable news
0
All posts from Actionable news
Actionable news in VRX: VALEANT PHARMACEUTICALS INTERNATIONAL,

Canaccord Raises Price Target for Valeant Pharmaceuticals International, Inc. (VRX) on Back of Credit Facility Amendment

Analyst Neil Maruoka of Canaccord raised his price target on Hold-rated Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) to $33 (from $31), after the drug maker announced that it has received lender consent for amendments to its credit facility.

Maruoka commented, “On balance, we view this as positive news for equity investors, but we believe that the company must still divest assets and execute operationally to fully turn the ship around. As we had noted following the quarter, the foundation has been...


More